Table 1.
Author | Years of Study | Country | Sample Size | Prevalence | Incidence* | Average Age at HZ Diagnosis |
---|---|---|---|---|---|---|
Retrospective Studies | ||||||
Wang [7] | 1975–1981 | Malaysia | 184 | 13% | NR | 34.6 (14–35)¥ |
Manzi [8] | 1979–1989 | United States | 321 | 15% | NR | NR |
Nagasawa [9] | 1979–1989 | Japan | 92 | 43% | 91.4 | 36.8 (19–68)¥ |
Sayeeda [10] | 1982–2006 | Saudi Arabia | 624 | 5.1% | NR | 31.4 (11–60)¥ |
Kang [11] | 1990–2000 | Korea | 303 | 13.9% | 32.5 | 34.1 (11.6)§ |
Chen [12] | 1996–2006 | Taiwan | 10,337 | N/A | 37.7 | 34.8 (14.3)§ |
Borba [13] | 1999–2006 | Brazil | 1,145 | 4.45% | 6.4 | 39 (13.7)§ |
Hata [14] | 2001–2007 | Japan | 1,077 | NR | 53.7 | 51.2 (20.9)§ |
Chakravarty [15] | 2001–2009 | United States | 1,485 | NR | 12 | NR |
Case Control Studies | ||||||
Moutsopoulos [16] | 1978 | Greece | 83 | 21% | NR | NR |
Strom [17] | 1985–1987 | United States | 195 | 9.2% | NR | NR |
Khal [18] | 1994 | United States | 348 | 13.5% | 16 | NR |
Ishikawa [19] | 1999 | Japan | 58 | 46.6% | NR | 40.2 (13.4)§ |
Pope [20] | 2004 | United Kingdom | 61 | 19% | NR | 49 (2)§ |
Incidence given in cases/1000 person-years
NR = Not reported
Mean (Range)
Range (Standard Deviation)